BIRC5 and gastric cancer: Those results indicated that survivin may be pivotal in the development of gastric cancer and resistance to CDDP and, therefore, controlling the expression of the survivin gene may be useful in the chemotherapy of gastric cancer, a hypothesis also supported by other studies (13,14).